BioSpace News Archive

Minimally Invasive Endobronchial Valve COPD Treatment with the Spiration® Valve System Now Available to Blue Cross Blue Shield Members in Illinois, Montana, New Mexico, Oklahoma, and Texas

Augmedix, a pioneer in the development of remote medical documentation, has been selected as a finalist for Red Herring’s Top 100 North America award, one of the technology industry’s most prestigious prizes.

As previously announced, during April 2020, Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga”) and Aegea Biotechnologies, Inc. (“Aegea”) have entered into a collaboration agreement to develop COVID-19 (novel coronavirus) assays.

The Allen Institute announced six new Next Generation Leaders, members of a unique neuroscience advisory panel made up of early-career researchers.

Evommune, Inc., an innovation engine in chronic inflammation, announced the successful completion of a $12.5 million seed financing by Pivotal bioVenture Partners.

Eurofins Viracor, a leading infectious disease testing laboratory for more than 35 years, announces the launch of several combined tests which detect COVID-19, influenza A/B, and respiratory syncytial virus (RSV)

NeurodigitX, the innovative digital health company, announced today a new comprehensive platform called Plastic Health™ that allows a powerful mainstream bloodless assessment of inflammation levels, first targeting the current pandemic, in an effort to supplement and enhance vaccine immunization strategies.

Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX), a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel therapeutics to treat cystic fibrosis and other diseases caused by nonsense mutations limiting production of functional proteins, is pleased to announce that Dr. Gregory Williams, Chief Executive Officer of Eloxx, will participate in a fireside chat and host one-on-one meetings with investors at the Piper Sandler 32nd Annual Virtual Growth Conference.

Invent Medical Corporation is pleased to announce the EUA approval on their HFT 150™ heated high flow system. Sam Chang, CEO comments, “After four years in development and based on multiple key opinion leaders input related to product design and features, we are poised to launch the HFT 150™ into the USA hospital markets early 2021

Nym Health, pioneers of Clinical Language Understanding (CLU) technology, today announced that Geisinger is deploying Nym’s autonomous medical coding technology to all nine of its hospital emergency departments.